189 related articles for article (PubMed ID: 8761588)
41. The effect of diethylcarbamazine treatment on the development of bancroftian microfilariae in Culex p. fatigans.
Chen CC; Fan PC
Southeast Asian J Trop Med Public Health; 1977 Mar; 8(1):53-5. PubMed ID: 329427
[TBL] [Abstract][Full Text] [Related]
42. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
Stolk WA; VAN Oortmarssen GJ; Pani SP; DE Vlas SJ; Subramanian S; DAS PK; Habbema JD
Am J Trop Med Hyg; 2005 Nov; 73(5):881-7. PubMed ID: 16282298
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of mass single-dose diethylcarbamazine and DEC-fortified salt against bancroftian filariasis in Papua New Guinea six months after treatment.
Sapak P; Williams G; Bryan J; Riley I
P N G Med J; 2000; 43(3-4):213-20. PubMed ID: 11939303
[TBL] [Abstract][Full Text] [Related]
44. Cytologic diagnosis of Bancroft's filariasis presenting as generalized lymphadenopathy.
Prasoon D; Gupta SK
Acta Cytol; 1997; 41(6):1862-4. PubMed ID: 9390162
[No Abstract] [Full Text] [Related]
45. A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for bancroftian filariasis.
Dreyer G; Amaral F; Norões J; Medeiros Z; Addiss D
Trans R Soc Trop Med Hyg; 1995; 89(2):225-6. PubMed ID: 7778157
[No Abstract] [Full Text] [Related]
46. Lymphadenovarix of the head-neck region--a rare presentation of Bancroftian filariasis.
Dwivedi RC; Gupta P; Dwivedi RC; Kishore K; Bhatia N
J Trop Pediatr; 2009 Oct; 55(5):332-4. PubMed ID: 19095694
[TBL] [Abstract][Full Text] [Related]
47. Double blind clinical trial on centperazine & DEC in bancroftian filariasis.
Rath RN; Das BK; Ali ML; Das PK; Mishra AC; Mohapatra BN
Indian J Med Res; 1990 Jul; 91():277-81. PubMed ID: 2228058
[TBL] [Abstract][Full Text] [Related]
48. Filarial vector studies in a diethylcarbamazine-treated and in untreated villages in Papua New Guinea.
Bryan JH; Dagoro H; Southgate BA
J Trop Med Hyg; 1995 Dec; 98(6):445-51. PubMed ID: 8544229
[TBL] [Abstract][Full Text] [Related]
49. Inappropriateness of the association of diphenhydramine with diethylcarbamazine for the treatment of lymphatic filariasis.
Dreyer G; de Andrade L
J Trop Med Hyg; 1989 Feb; 92(1):32-4. PubMed ID: 2645415
[TBL] [Abstract][Full Text] [Related]
50. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
Ramaiah KD; Vanamail P; Das PK
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
[TBL] [Abstract][Full Text] [Related]
51. Chemotherapy with spaced doses of diethylcarbamazine preceded by levamisole on Bancroftian filariasis.
Temu SE; McMahon JE
Trans R Soc Trop Med Hyg; 1981; 75(6):835-7. PubMed ID: 7036437
[TBL] [Abstract][Full Text] [Related]
52. Can vector control play a useful supplementary role against bancroftian filariasis?
Maxwell CA; Mohammed K; Kisumku U; Curtis CF
Bull World Health Organ; 1999; 77(2):138-43. PubMed ID: 10083712
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
Yongyuth P; Koyadun S; Jaturabundit N; Sampuch A; Bhumiratana A
J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435
[TBL] [Abstract][Full Text] [Related]
54. [Furapyrimidone in the treatment of bancroftian filariasis].
Ren YF
Zhonghua Nei Ke Za Zhi; 1985 Apr; 24(4):221-3, 255. PubMed ID: 3891251
[No Abstract] [Full Text] [Related]
55. Duration of diethylcarbamazine treatment and clearance of microfilaraemia in bancroftian filariasis.
Sethumadhavan KV; Ravindranathan TC; Babu CS; Roychowdhury SP; Narasimham MV; Kanoujia KH; Sharma SP; Rao CK
J Commun Dis; 1980 Mar; 12(1):34-8. PubMed ID: 7005315
[No Abstract] [Full Text] [Related]
56. Efficacy of co-administered diethylcarbamazine and albendazole against adult Wuchereria bancrofti.
Dreyer G; Addiss D; Williamson J; Norões J
Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1118-25. PubMed ID: 16860830
[TBL] [Abstract][Full Text] [Related]
57. Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection.
McCarthy JS; Guinea A; Weil GJ; Ottesen EA
J Infect Dis; 1995 Aug; 172(2):521-6. PubMed ID: 7622896
[TBL] [Abstract][Full Text] [Related]
58. Lymphatic filariasis in children: adenopathy and its evolution in two young girls.
Dreyer G; Figueredo-Silva J; Carvalho K; Amaral F; Ottesen EA
Am J Trop Med Hyg; 2001 Sep; 65(3):204-7. PubMed ID: 11561705
[TBL] [Abstract][Full Text] [Related]
59. A great success in lymphatic filariasis control in China. National Technical Steering Group for Filariasis Control and Research, MOPH.
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):81-5. PubMed ID: 7554168
[TBL] [Abstract][Full Text] [Related]
60. Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin.
Weil GJ; Lammie PJ; Richards FO; Eberhard ML
J Infect Dis; 1991 Oct; 164(4):814-6. PubMed ID: 1894943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
